[Bioavailability of natural versus synthetic B vitamins and their effects on metabolic processes].

Bioverfügbarkeit eines natürlichen versus eines synthetischen Vitamin-B- Komplexes und deren Auswirkungen auf metabolische Prozesse.

Journal

MMW Fortschritte der Medizin
ISSN: 1613-3560
Titre abrégé: MMW Fortschr Med
Pays: Germany
ID NLM: 100893959

Informations de publication

Date de publication:
03 2020
Historique:
received: 25 09 2019
accepted: 12 11 2019
entrez: 20 3 2020
pubmed: 20 3 2020
medline: 21 7 2020
Statut: ppublish

Résumé

Owing to the widespread use of vitamin supplements to prevent and compensate for deficiencies, the equivalence of natural versus synthetic vitamins with respect to their bioavailability and metabolic influence is discussed controversially. Thirty healthy female (n=22) and male participants (n=8) were investigated in a randomized, double-blind, cross-over study over a supplementation period of 6 weeks for each condition. The participants received a daily dose of a complex of the 8 natural B vitamins (group N), determined by the natural composition of quinoa seedlings, resp. synthetic B vitamins (group S), both corresponding to about 2.5 times the Recommended Dietary Allowance (RDA) of the national nutrition board. The primary criterion under investigation was changes in the blood levels of the individual B vitamins. Secondary criteria were the influence of both B complexes on homocysteine, antioxidant status, polyphenols, peroxide loading and peroxidase activity. Compared to baseline values, serum levels of all B vitamins measured increased: Vitamins B1 (N +23%; S +27%), B2 (N +14%; S +13%), B6 (N +101%; S +101%), B9 (N +86%; S +153%) and B12 (N +16%) were elevated at the end of the first supplementation period (p < 0.05), while serum levels of vitamins B1, B9 and B12 remained elevated compared to baseline even after the 2-week washout phase. During the second supplementation period, the vitamin concentrations in group N, with the exception of vitamin B1, could be increased once again (p < 0.05). In contrast, in group S only for vitamins B2 and B12 substantial increases (p < 0.05) were found. The influence of B vitamins on metabolic parameters such as homocysteine and polyphenols, which were markedly reduced, was also clearly measurable; however, total antioxidant capacity and peroxidase activity increased. The peroxide concentration remained almost unchanged in both groups. This clinical pilot study showed comparable bioavailability for both natural and synthetic B vitamins, with a 2.5-fold concentration of the RDA. Both vitamin B preparations showed a clear influence on metabolic parameters, whereas that of the natural B vitamins tended to have a slightly stronger effect than the synthetic analogues.

Sections du résumé

BACKGROUND
Owing to the widespread use of vitamin supplements to prevent and compensate for deficiencies, the equivalence of natural versus synthetic vitamins with respect to their bioavailability and metabolic influence is discussed controversially.
METHOD
Thirty healthy female (n=22) and male participants (n=8) were investigated in a randomized, double-blind, cross-over study over a supplementation period of 6 weeks for each condition. The participants received a daily dose of a complex of the 8 natural B vitamins (group N), determined by the natural composition of quinoa seedlings, resp. synthetic B vitamins (group S), both corresponding to about 2.5 times the Recommended Dietary Allowance (RDA) of the national nutrition board. The primary criterion under investigation was changes in the blood levels of the individual B vitamins. Secondary criteria were the influence of both B complexes on homocysteine, antioxidant status, polyphenols, peroxide loading and peroxidase activity.
RESULTS
Compared to baseline values, serum levels of all B vitamins measured increased: Vitamins B1 (N +23%; S +27%), B2 (N +14%; S +13%), B6 (N +101%; S +101%), B9 (N +86%; S +153%) and B12 (N +16%) were elevated at the end of the first supplementation period (p < 0.05), while serum levels of vitamins B1, B9 and B12 remained elevated compared to baseline even after the 2-week washout phase. During the second supplementation period, the vitamin concentrations in group N, with the exception of vitamin B1, could be increased once again (p < 0.05). In contrast, in group S only for vitamins B2 and B12 substantial increases (p < 0.05) were found. The influence of B vitamins on metabolic parameters such as homocysteine and polyphenols, which were markedly reduced, was also clearly measurable; however, total antioxidant capacity and peroxidase activity increased. The peroxide concentration remained almost unchanged in both groups.
CONCLUSION
This clinical pilot study showed comparable bioavailability for both natural and synthetic B vitamins, with a 2.5-fold concentration of the RDA. Both vitamin B preparations showed a clear influence on metabolic parameters, whereas that of the natural B vitamins tended to have a slightly stronger effect than the synthetic analogues.

Identifiants

pubmed: 32189314
doi: 10.1007/s15006-020-0230-4
pii: 10.1007/s15006-020-0230-4
doi:

Substances chimiques

Vitamins 0
Homocysteine 0LVT1QZ0BA
Vitamin B Complex 12001-76-2
Folic Acid 935E97BOY8
Vitamin B 12 P6YC3EG204

Types de publication

Journal Article Randomized Controlled Trial

Langues

ger

Sous-ensembles de citation

IM

Pagination

17-27

Auteurs

Meinrad Lindschinger (M)

Institut für Ernährung und Stoffwechselerkrankungen, Laßnitzhöhe, Austria.

Franz Tatzber (F)

Otto Loewi Forschungszentrum, Lehrstuhl für Immunologie und Pathophysiologie, Medizinische Universität Graz, Graz, Austria.

Wolfgang Schimetta (W)

Abteilung für Angewandte Systemforschung und Statistik, Johannes Kepler Universität Linz, Linz, Austria.

Irene Schmid (I)

Institut für Ernährung und Stoffwechselerkrankungen, Laßnitzhöhe, Austria.

Barbara Lindschinger (B)

Institut für Ernährung und Stoffwechselerkrankungen, Laßnitzhöhe, Austria.

Gerhard Cvirn (G)

Otto Loewi Forschungszentrum, Lehrstuhl für Physiologische Chemie, Medizinische Universität Graz, Neue Stiftingtalstraße 6 M1/D3, A-8010, Graz, Austria.

Norbert Fuchs (N)

Institut für Nährstofftherapie, Lungau, Austria.

Gertrude Markolin (G)

Institut für Nährstofftherapie, Lungau, Austria.

Eugenia Lamont (E)

Klinische Abteilung für Gefäßforschung, Universitätsklinik für Chirurgie, Medizinische Universität Graz, Graz, Austria.

Willibald Wonisch (W)

Otto Loewi Forschungszentrum, Lehrstuhl für Physiologische Chemie, Medizinische Universität Graz, Neue Stiftingtalstraße 6 M1/D3, A-8010, Graz, Austria. willibald.wonisch@medunigraz.at.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH